Skip to main content

Ra Capital Management, L.P.

Source: SEC Form 13F · as of Mar 2026

Ra Capital Management, L.P. holds 39 biotech & pharma companies tracked by BioSniper, totaling $3.91B in value as of Mar 2026 (SEC Form 13F).

Companies held

39

Total value held

$3.91B

BioSniper AIPage evidence connected

Prepared research question

What matters most for Vaxcyte, Inc. (PCVX)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
PCVXVaxcyte, Inc.11,474,599$666.8M
RYTMRHYTHM PHARMACEUTICALS, INC.6,666,837$579.8M
SIONSionna Therapeutics, Inc.9,905,045$397.1M
NAMSNEWAMSTERDAM PHARMA CO N.V.9,550,191$305.7M
NUVLNuvalent, Inc.2,534,145$259.6M
DNTHDianthus Therapeutics, Inc. /DE/2,611,733$219.2M
IRONDisc Medicine, Inc.2,450,221$156.7M
BCAXBicara Therapeutics Inc.7,255,993$144.3M
GHRSGH Research PLC7,676,697$107.9M
GERNGERON CORP63,771,366$95.0M
SPRYARS Pharmaceuticals, Inc.10,860,977$87.2M
SYRESpyre Therapeutics, Inc.1,621,620$81.8M
CLYMClimb Bio, Inc.11,300,939$77.4M
SLDBSolid Biosciences Inc.9,339,978$67.2M
DMRADamora Therapeutics, Inc.2,399,310$62.1M
LBRXLB PHARMACEUTICALS INC2,208,604$54.5M
JBIOJade Biosciences, Inc.3,671,083$51.6M
FDMT4D Molecular Therapeutics, Inc.5,049,779$47.0M
CAPRCAPRICOR THERAPEUTICS, INC.1,507,844$45.8M
OLMAOlema Pharmaceuticals, Inc.2,600,000$38.8M
LENZLENZ Therapeutics, Inc.4,178,823$38.2M
DSGNDesign Therapeutics, Inc.2,972,973$31.6M
BIOABioAge Labs, Inc.1,650,648$28.9M
ASMBASSEMBLY BIOSCIENCES, INC.1,020,410$28.3M
RZLTRezolute, Inc.9,180,000$28.0M
ALXOALX ONCOLOGY HOLDINGS INC13,011,849$26.1M
OVIDOvid Therapeutics Inc.10,714,000$23.8M
TVTXTravere Therapeutics, Inc.746,841$22.2M
CCCCC4 Therapeutics, Inc.8,000,000$21.0M
RLMDRELMADA THERAPEUTICS, INC.2,947,369$20.5M
STROSUTRO BIOPHARMA, INC.715,307$17.8M
SABSSAB BIOTHERAPEUTICS, INC.4,401,500$16.9M
OKUROnKure Therapeutics, Inc.3,998,333$16.6M
RNAAtrium Therapeutics Inc.864,102$11.6M
AVTXAvalo Therapeutics, Inc.662,968$9.9M
ACETAdicet Bio, Inc.1,182,624$8.1M
HOWLWerewolf Therapeutics, Inc.6,681,307$5.6M
MPLTMapLight Therapeutics, Inc.248,294$5.0M
PTNPALATIN TECHNOLOGIES INC70,000$1.2M

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.